Skip to content
Tracking Global Approvals

Regulatory approvals, pending decisions, and appeals as of February 2026.

Faster Rollout for LEN

The timeline for hitting key milestones in product introduction is moving faster for injectable LEN than for any previous PrEP products, starting from the announcement of efficacy results in Phase III trials. LEN’s accelerated timeline compared to oral PrEP, DVR, and CAB reflects a field-wide effort to learn lessons from previous PrEP rollout and not repeat the mistakes of the past.

Choice Counselling: A conversation that centres the wants and needs of potential PrEP users

Read the Story